NOT - FREEFALL Possible for NOTUSDT NOT is short term bearish as we lose the higher-highs and form a bearish M-Pattern in the daily timeframe.
In an earlier post, I made an important note on how to trade newly released altcoins - and share a key fact that is might come handy for NOTusdt:
Additionally, we've fallen below the 50d Moving averages in the daily timeframe - also a bearish indicator for the immediate term.
Don't miss this update on BTC, as BTC will determine the direction of most of the market:
_______________________
BINANCE:NOTUSDT
Noticias
#NOT/USDT#NOT
The price is moving in an ascending channel on the 1-hour frame and is sticking to it greatly and is about to break upwards
Some decline is expected to touch the lower limit of the channel
We have a bounce from the lower limit of the channel at a price of 0.007000
We have an upward trend on the RSI indicator about to break, which supports the rise
We have a trend to stabilize above the moving average 100
Entry price 0.007459
First target 0.007980
Second target 0.008738
Third target 0.009700
NOTcoin chartAnalysis by Amadarz✅
This chart for NOT/USDT suggests a bearish trend that is now consolidating, with a descending trendline. Here's a breakdown of the setup:
1. Current Price : 0.01061 USDT 📉.
2. Trendline Break : The setup is recommending to wait for a break of the descending trendline ⏳ before entering a long position. This is crucial as it would signal a potential trend reversal or bullish continuation 📈.
3. Second Entry : There’s a potential second entry at 0.00912 USDT 🚪, a key level based on previous support.
4. Target Levels 🎯:
- TP1 : 0.01114 USDT 🟢 (minor resistance level).
- TP2 : 0.01229 USDT 🟢 (further resistance).
- TP3 : 0.01435 USDT 🏁 (approaching a significant resistance).
5. Stop-Loss Zones : Recommended stop-loss is between 0.00907 USDT and 0.00857 USDT 🔴, just below the recent major swing low.
Key Observations:
- Risk Management : The stop-loss below 0.00912 ensures solid risk control 🔒, protecting your downside below the recent low.
- Action Plan : If the trendline breaks with strong volume or bullish confirmation 🚀, consider taking profits at the targets in sequence, with TP1 being conservative, and TP3 offering the maximum reward 🎉.
Keep an eye 👀 on the volume and price action around the trendline for confirmation of the breakout!
#NOT/USDT#NOT
The price is moving within a descending channel pattern on the 1-hour frame and is expected to rise after it has been largely committed to it
We have a downtrend on the RSI indicator that is expected to break upwards and we have a trend to stabilize above it
We have a major support level in green at a price of 0.01250
We have a trend to stabilize above the moving average 100
Entry price 0.01260
First target 0.01340
Second target 0.01400
Third target 0.01460
#NOT/USDT#NOT
The price is moving within a descending channel pattern on the 4-hour frame, which is a retracement pattern
We have a bounce from a major support area in the color EUR at 0.012000
We have a tendency to stabilize above the Moving Average 100
We have a downtrend on the RSI indicator that supports the rise and gives greater momentum and the price is based on it
Entry price is 0.013800
The first target is 0.017810
The second goal is 0.021840
The third goal is 0.02540
Trading Signal For NOTUSDT Trading Setup:
A Trading Signal is seen in the NOTUSDT NotcoinCommunity
Traders can open their Buy Trades NOW
⬆️Buy now or Buy on 0.020857
⭕️SL @ 0.016337
🔵TP1 @ 0.030000
🔵TP2 @ 0.038000
🔵TP3 @ 0.045000
previous idea
What are these signals based on?
Classical Technical Analysis
Price Action Candlesticks Fibonacci
RSI, Moving Average , Ichimoku , Bollinger Bands
Risk Warning
Trading Forex, CFDs, Crypto, Futures, and Stocks involve a risk of loss. Please consider carefully if such trading is appropriate for you. Past performance is not indicative of future results.
If you liked our ideas, please support us with your likes 👍 and comments .
Grifols: A new bullish channel up to +18%?Focused on hemoderivatives (blood plasma), Grifols is great value by most of investors. Even though the company might be one day spitted by any scandal on how it is gathering the plasma in the US, americans have got a high stake on it and today it is focusing on an hyperimmune immunoglobulin with specific antibodies against the SARS-CoV-2 virus. Grifols estimated an impact on its accounts of €200 million and many rating houses have downgraded the stock. Its 2019's profits were up 4.8% to 625 million and an EBITDA of 1,434 million (+17,3% YoY). In 2020, Q1 Net profits were up 63% and EBITDA 14.9%. Results on its tests will be presented in July (the mandatory 14 days to see whether the virus is gone or not). We may experience volatility in the price of the company until July 01. According to some news, Grifols' margins were not attractive and that is why the correction of the share price has taken place.
Technically speaking, the company might be immersed in a bullish channel started on March 16 and closing out a triangle started on Feb 20. We could expect the share price go at least up to 29.40 level in the next days. Best price to enter Grifols might be 27€. Also, note that when markets are down, Grifols is up acting like a safe haven asset.